Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444639
Status:
TERMINATED
Last Update Posted:
2019-11-22
First Post:
2007-03-07
Brief Title:
Study to Assess the Non-inferiority of Pamorelin 1125mg SC Injected Versus Pamorelin 1125mg IM Injected in Patients Suffering From Advanced Prostate Cancer PAMOJECT
Sponsor:
Organization:
Ipsen
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
25
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: